ATE63463T1 - Behandlung chronischer entzuendungskrankheiten. - Google Patents

Behandlung chronischer entzuendungskrankheiten.

Info

Publication number
ATE63463T1
ATE63463T1 AT86810340T AT86810340T ATE63463T1 AT E63463 T1 ATE63463 T1 AT E63463T1 AT 86810340 T AT86810340 T AT 86810340T AT 86810340 T AT86810340 T AT 86810340T AT E63463 T1 ATE63463 T1 AT E63463T1
Authority
AT
Austria
Prior art keywords
chronic inflammatory
treatment
inflammatory diseases
disease
venously
Prior art date
Application number
AT86810340T
Other languages
English (en)
Inventor
Alfred Haessig
Original Assignee
Schweiz Rotes Kreuz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10583453&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE63463(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schweiz Rotes Kreuz filed Critical Schweiz Rotes Kreuz
Application granted granted Critical
Publication of ATE63463T1 publication Critical patent/ATE63463T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT86810340T 1985-08-07 1986-07-29 Behandlung chronischer entzuendungskrankheiten. ATE63463T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858519848A GB8519848D0 (en) 1985-08-07 1985-08-07 Treatment of chronic inflammatory disease
EP86810340A EP0213072B1 (de) 1985-08-07 1986-07-29 Behandlung chronischer Entzündungskrankheiten

Publications (1)

Publication Number Publication Date
ATE63463T1 true ATE63463T1 (de) 1991-06-15

Family

ID=10583453

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86810340T ATE63463T1 (de) 1985-08-07 1986-07-29 Behandlung chronischer entzuendungskrankheiten.

Country Status (10)

Country Link
US (1) US4676982A (de)
EP (1) EP0213072B1 (de)
JP (1) JPS6253931A (de)
AT (1) ATE63463T1 (de)
AU (1) AU599037B2 (de)
DE (1) DE3679255D1 (de)
DK (1) DK376386A (de)
GB (1) GB8519848D0 (de)
PH (1) PH21275A (de)
ZA (1) ZA865950B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2123338C1 (ru) * 1990-06-15 1998-12-20 Сайтел Корпорейшн Фармацевтическая композиция на основе медиатора межклеточной адгезии (варианты), способ ингибирования межклеточной адгезии, способ лечения воспалительного заболевания, способ анализа тестируемого соединения на способность ингибировать клеточную адгезию, способ получения соединения
ATE173630T1 (de) * 1992-12-29 1998-12-15 Genentech Inc Behandlung von entzündlichen darmerkrankungen mit interferon-gamma-inhibitoren
US6395273B1 (en) 1998-06-10 2002-05-28 Promega Corporation Prevention and treatment of inflammatory bowel disease
US6767564B2 (en) * 2000-09-02 2004-07-27 The Trustees Of The University Of Pennsylvania Use of bowman birk inhibitor for the treatment of multiple sclerosis and other autoimmune diseases
RU2215546C1 (ru) * 2002-03-29 2003-11-10 Алтайский государственный медицинский университет Способ лечения неспецифического язвенного колита

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH392780A (de) * 1961-12-07 1965-05-31 Schweiz Rotes Kreuz Verfahren zur Herstellung von intravenös anwendbaren Antikörperpräparaten humanen Ursprungs
JPS5296731A (en) * 1976-02-05 1977-08-13 Green Cross Corp:The Prophylactics and remedies of cyanomycosis
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
NZ201698A (en) * 1981-08-31 1985-12-13 S L Gaffin Composition of antibodies specific to endotoxins
EP0085747B2 (de) * 1982-02-08 1990-05-30 Schweizerisches Serum- und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten Intravenös verabreichbares humanes Immunglobulin und Verfahren zu dessen Herstellung
DK166763B1 (da) * 1983-03-16 1993-07-12 Immuno Ag Immunoglobulin-g-holdig fraktion
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
US4617266A (en) * 1983-04-28 1986-10-14 Genex Corporation Production of Protein A
CA1260828A (en) * 1983-07-04 1989-09-26 Masakazu Iwai Therapeutic and prophylactic agent for gastrointestinal ulcers
DE3340487A1 (de) * 1983-11-09 1985-05-15 Sandoz-Patent-GmbH, 7850 Lörrach Neue therapeutische verwendung

Also Published As

Publication number Publication date
GB8519848D0 (en) 1985-09-11
DK376386D0 (da) 1986-08-06
ZA865950B (en) 1988-03-30
EP0213072B1 (de) 1991-05-15
DK376386A (da) 1987-02-08
AU6089086A (en) 1987-02-12
EP0213072A2 (de) 1987-03-04
EP0213072A3 (en) 1987-09-30
PH21275A (en) 1987-09-28
JPS6253931A (ja) 1987-03-09
US4676982A (en) 1987-06-30
DE3679255D1 (de) 1991-06-20
AU599037B2 (en) 1990-07-12

Similar Documents

Publication Publication Date Title
DE69129800D1 (de) Behandlung von menschlichen retrovirus-infektionen mit 2',3'-dideoxyinosin
JPS57193412A (en) Prevention of prostatic hyperplasia and therapeutical drug
DE3587741D1 (de) Behandlung von Hautkrankheiten.
KR890002547A (ko) Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드
IT8267970A0 (it) Dispositivo per la somministrazione per via parenterale di agenti benefici particolarmente sangue e suoi sostituti
EP0270690A4 (de) Arzneimittel zur behandlung und prophylaxe von leber- und nierenkrankheiten.
DE69110713D1 (de) 7-Oxabicycloheptan-imidazol-prostaglandin-Analoge, verwendbar bei der Behandlung von thrombotischen und vasospastischen Erkrankungen.
DE69118978D1 (de) Behandlung von entzündlichen Erkrankungen mit 15-Ketoprostaglandinen
DK435678A (da) Fremgangsmaade til paavisning af sygdomsvaekkere i blod
DE3381624D1 (de) Mittel zur behandlung von wunden.
DK0413329T3 (da) 5-methyl-isoxazol-4-carboxylsyreanilider og 2-hydroxyethyliden-cyaneddikesyreanilider til behandling af øjensygdomme
ATE63463T1 (de) Behandlung chronischer entzuendungskrankheiten.
EP0339163A3 (en) Monoclonal antibodies specific for hiv and hybridomas for their production
BE891629A (fr) Promoteur de coagulation du sang et procede l'utilisant
FI844645L (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
NO142500C (no) Apparat til behandling av blod.
NO881255D0 (no) Behandling av fluider.
NO883603L (no) Humane monoklonale antistoffer og profylaktiske og terapeutiske midler mot infektioese sykdommer inneholdende disse som effektiv bestanddel.
FI823761A7 (fi) Immuunikompleksin poistaminen ja kasvaimelle spesifisen vasta- aineen muodostaminen perfusoinnilla tuetproteiinin A:n yli ja perfusoinnin jälkeisellä lääkeinfuusiolla.
DE3674321D1 (de) Behandlung geschmeidiger gewebe.
SE8306384L (sv) Farmaceutisk komposition
IT8148480A0 (it) Composizione terapeutica e sistema per il trattamento extracorporeo di sangue intero
BG44873A3 (bg) Метод за получаване на кондензирани аs-триазини
ATE63731T1 (de) Behandlung von gasstroemen.
RO81791A2 (ro) Comprimate pentru tratamentul uremiilor feriprive

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RZN Patent revoked